Kintur Sanghvi, MD
Interventional Cardiology · Bordentown, NJNPI 1770627200
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (47.7%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. Medtronic accounts for 60.3% of it on its own, with 27 other manufacturers making up the rest. 2025 is the largest year on record at $52,631, 2.1 times the $24,970 reported in 2019. Among interventional cardiology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 271 payments — averaging $513.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$84K
- Cordis Corporation$26K
- Cardinal Health 200 LLC$19K
- Cordis US CORP.$4K
- Edwards Lifesciences$2K
- Penumbra, Inc.$574
- plus $3K from 22 others
Across 143 payments — averaging $2291.77 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$204K
- Recor Medical Inc$97K
- Cardiovascular Systems Inc.$27K
What the payments were for
- Royalty or licence$10,9458%
- Consulting fees$66,29748%
- Speaking & faculty fees$12,7819%
- Grants$1400%
- Travel & lodging$38,98828%
- Food & beverage$9,8997%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 152 | $83,805 |
| Cordis Corporation | 2 | $25,807 |
| Cardinal Health 200 LLC | 22 | $19,344 |
| Cordis US CORP. | 6 | $4,282 |
| Edwards Lifesciences | 13 | $1,785 |
| Penumbra, Inc. | 7 | $574 |
| Boston Scientific | 19 | $565 |
| Abiomed | 9 | $547 |
| Nevro Corp. | 6 | $503 |
| Siemens Medical Solutions USA, Inc. | 1 | $360 |
| Cardiovascular Systems Inc. | 4 | $322 |
| Inari Medical, Inc. | 3 | $314 |
| W. L. Gore & Associates, Inc. | 2 | $214 |
| Shockwave Medical, Inc | 4 | $194 |
| Merck | 6 | $162 |
| Angiodynamics, Inc. | 2 | $41 |
| Recor Medical Inc | 1 | $37 |
| Amgen | 2 | $30 |
| Abbott | 1 | $23 |
| Chiesi USA, Inc. | 1 | $22 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $19 |
| Kestra Medical Technology Services, Inc. | 1 | $18 |
| AstraZeneca | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Irhythm Technologies, Inc. | 1 | $16 |
| Alnylam Pharmaceuticals Inc. | 1 | $13 |
| Bardy Diagnostics, Inc. | 1 | $12 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYMPLICITY G3$37,782
- RAILWAYTM$15,248
- MYNX CONTROLTM$7,866
- EluNIR Radaforolimus Eluting Coronary Stent System$5,466
- RAIN SheathTM$4,648
- ZEPHER$4,648
- Resolute$4,628
- RAILWAY$1,733
- Edwards SAPIEN 3 Transcatheter Heart Valve$1,019
- COREVALVE EVOLUT R$541
- Indigo System$511
- CoreValve Evolut$469
- IN.PACT Admiral$464
- Artis icono floor$360
- ARTIS icono biplane$360
- FLOWTRIEVER CATHETER, S$291
- CT THROMBECTOMY SYSTEM KIT$291
- Omnia$208
- EVOQUE$196
- Impella$150
How this compares
$139,050 in reported general payments places this provider in the 95th percentile of 166 interventional cardiology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 111 | $129,762 |
| EntrestoSacubitril/Valsartan | 25 | $41,527 |
| XareltoRivaroxaban | 14 | $21,965 |
| Metoprolol Succinate | 278 | $3,974 |
| Rosuvastatin Calcium | 81 | $1,635 |
| Valsartan | 46 | $1,601 |
| Amiodarone Hcl | 27 | $1,266 |
| ClopidogrelClopidogrel Bisulfate | 108 | $1,155 |
| Atorvastatin Calcium | 129 | $985 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 13 | $705 |
| Carvedilol | 42 | $606 |
| Amlodipine Besylate | 74 | $421 |
| Furosemide | 75 | $390 |
| Losartan Potassium | 44 | $370 |
| Ezetimibe | 11 | $272 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Bordentown
- Ankitkumar PatelGlen Ridge$408K
- Ziad AbbudOcean$360K
- Ramin HastingsHasbrouck Heights$295K
- Michael LimHackensack$215K
- Darshan GodkarCedar Knolls$194K
- Ryan KapleHackensack$178K
- Matthew SayboltEatontown$175K
- Daniel KissEatontown$172K
- Dimitrios KarmpaliotisMorristown$129K
- Sung-Han YoonHackensack$105K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.